At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
09939 KINTOR PHARMA-B
Not Yet Opened 09-17 16:08:07
1.890
+0.010
+0.53%
High1.900
Low1.800
Vol771.50K
Open1.880
D1 Closing1.880
Amplitude5.32%
Mkt Cap943.11M
Tradable Cap943.11M
Total Shares499.00M
T/O1.43M
T/O Rate0.15%
Tradable Shares499.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Chairman and CEO Acquires Additional Shares in TYK MEDICINES-B (02410), Purchasing 120,000 Shares at HK$3.486 Each
Hong Kong Stock Market Flash | TYK Medicines-B Surges Over 9% as Chairman's Share Buyback Reinforces Confidence and Novel EGFR-TKI Gains Landmark Approval
Kintor Pharmaceutical Ltd is an investment holding company primarily engaged in the research and development of innovative medicine products. The Company's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers indications of dermatology (such as androgenetic alopecia, acne vulgaris) and indications of tumors. The Company has two core drugs in the dermatology field, KX-826 and GT20029. The Company's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.